Association of Helicobacter pylori infection with inflammatory cytokine expression in patients with gallbladder cancer

Indian Journal of Gastroenterology

Volumn 32, Issue 4, 2013, Pages 232-235

  Mishra, Raghvendra Raman ^a   Tewari, Mallika ^a   Shukla, Hari S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Interferon ; Interleukin 1 ; Interleukin 5; Pathogenesis; Tumor necrosis factor

Indexed keywords

BACTERIAL ENZYME; CATALASE; GAMMA INTERFERON; HELICOUREASE; INTERLEUKIN 1BETA; INTERLEUKIN 5; OXIDOREDUCTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM IDENTIFICATION; BIOCHEMISTRY; BLOOD SAMPLING; CANCER TISSUE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINESIS; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GALLBLADDER CANCER; GENE; GENE AMPLIFICATION; GENE SEQUENCE; GRAM STAINING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HSP60 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THORAX RADIOGRAPHY; TISSUE CULTURE;

CYTOKINES; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALLBLADDER NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; POLYMERASE CHAIN REACTION;

EID: 84879685297     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0321-6     Document Type: Article

References (32)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents, Vol VIII. Lyon: IARC; 2002. IARC Sci. Pub no. 155.
2. Shukla HS. Gallbladder cancer. J Surg Oncol. 2006;8: 604-6.
3. Maurya SK, Tewari M, Mishra RR, Shukla HS. Genetic aberrations in gallbladder cancer. Surg Oncol. 2012;21: 37-43.
4. Fraumeni JF, Hoover RN, Devesa SS, Kinlen LJ. Epidemiology of cancer. In: DeVita VT Jr, ed. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott; 1989. p. 198-27.
5. Mishra RR, Tewari M, Shukla HS. Helicobacter species and pathogenesis of gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2010;9: 129-34.
6. Tewari M, Mishra RR, Shukla HS. Salmonella typhi and gallbladder carcinoma: report from an endemic region. Hepatobiliary Pancreat Dis Int. 2010;9: 458-64.
7. Tewari M, Kumar V, Mishra RR, Shukla HS. Gallbladder carcinoid masquerading as gallbladder carcinoma. A case report. Hepatobiliary Pancreat Dis Int. 2009;8: 121-3.
8. Kumar S, Kumar S, Kumar S. Infection as a risk factor for gallbladder cancer. J Surg Oncol. 2006;93: 633-9.
9. Shukla HS, Tewari M. Discovery of Helicobacter pylori in gallbladder. Indian J Gastroenterol. 2012;31: 1-2.
10. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol. 1996;215: 3-10.
11. D'Elios MM, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol. 1997;27: 1751-5.
12. Genta RM. The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis. 1997;8: 2-11.
13. Lindholm C, Rbrink Q-JA, Nroth HLO, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun. 1998;66: 5964-71.
14. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD41 cells. Annu Rev Immunol. 1994;12: 635-73.
15. Mishra RR, Tewari M, Shukla HS. Helicobacter pylori and pathogenesis of gallbladder cancer. J Gastroenterol Hepatol. 2011;26: 260-6.
16. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993;341: 1359-62.
17. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 2006;28: 4-14.
18. Mannick EE, Bravo LE, Zarama G, et al. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effects of antibiotics and antioxidants. Cancer Res. 1996;56: 3238-43.
19. Baik SC, Youn HS, Chung MH, et al. Increased oxidative DNA damage in Helicobacter pylori infected human gastric mucosa. Cancer Res. 1996;56: 1279-82.
20. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol. 1991;6: 105-13.
21. Parsonnet J, Hansen S, Rodrigues L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330: 1267-71.
22. Crabtree JE. Role of cytokines in pathogenesis of Helicobacter pylori induced mucosal damage. Dig Dis Sci. 1998;43: 46S-55.
23. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med. 2002;33: 323-36.
24. Klausz G, Tiszai A, Tiszlavicz L, et al. Local and peripheral cytokine response and CagA status of Helicobacter pylori-positive patients with duodenal ulcer. Eur Cytokine Netw. 2003;14: 143-8.
25. Uedo N, Tatsuta M, Hirasawa HR, Iishi H, Otani T, Ishiguro S. Eradication of Helicobacter pylori decreases production of interleukin-1 beta and extends acid-secreting areas in gastric ulcer patients. Gastrointest Endosc. 1999;49: 192-9.
26. Hasegawaa S, Nishikawaa S, Miuraa T, et al. Tumor necrosis factor-α is required for gastritis induced by Helicobacter felis infection in mice. Microb Pathog. 2004;37: 119-24.
27. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29: 425-9.
28. Bauditz J, Ortner M, Bierbaum M, Niedobidek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol. 1999;117: 316-23.
29. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol. 1996;156: 4729-38.
30. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ. Murine CD4 T-cell response to Helicobacter pylori infection Th1 cell enhance gastritis and Th2 cell reduce bacterial load. Gastroenterology. 1997;113: 1848-57.
31. Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, Weinstock JV. Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci. 2003;100: 12944-9.
32. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun. 1999;67: 279-85.